Mark Jacobson
Geschäftsführer bei AXSOME THERAPEUTICS, INC.
Vermögen: 424 646 $ am 31.05.2024
Aktive Positionen von Mark Jacobson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AXSOME THERAPEUTICS, INC. | Geschäftsführer | 01.04.2014 | - |
Investor Relations Kontakt | 01.04.2014 | - | |
Unternehmenssekretär | 01.10.2015 | - |
Karriereverlauf von Mark Jacobson
Ehemalige bekannte Positionen von Mark Jacobson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2009 | 01.03.2014 |
Ausbildung von Mark Jacobson
Iowa State University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AXSOME THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Mark Jacobson
- Erfahrung